Angelica Kohlmann

Angelica Kohlmann, a pioneer in healthcare technology, established Bloom Diagnostics in 2018 with the vision to enable individuals to take charge of their health through technological advancements. With a medicine background and expertise gained from the pharmaceutical and venture capital industries, she was inspired to become an entrepreneur. As the Chairman of the Board for Bloom Diagnostics and Lonza, Angelica has played a crucial role in their success and growth. Her dedication to leveraging technology to improve healthcare outcomes has earned her various awards and recognition.

Angelica Kohlmann is a prominent figure in the world of healthcare technology, having founded Bloom Diagnostics in 2018. Her mission was to empower individuals to take control of their own health using the latest in technological advancements. Born and raised in Germany, Angelica was always interested in science and medicine. This passion led her to pursue a PhD in medicine, where she studied cancer research.

After completing her PhD, Angelica worked in various positions in the pharmaceutical industry, gaining valuable experience in product development, marketing, and sales. She eventually transitioned into the world of venture capital, where she focused on investing in and mentoring early-stage companies in the life sciences industry. During this time, Angelica gained a deep understanding of what it takes to grow a successful startup and achieve a profitable exit.

It was this experience that ultimately inspired Angelica to become a founder herself. She recognized the potential of digital health to transform the way people approach their health and wellness, and set out to create a company that would make this a reality. In 2018, she founded Bloom Diagnostics, a healthcare technology company that develops innovative diagnostic tools and solutions to help individuals take control of their own health.

As the Chairman of the Board of Directors for both Bloom Diagnostics and Lonza, Angelica brings a wealth of experience and expertise to her roles. Her leadership has been instrumental in guiding the growth and success of both companies. Under her guidance, Bloom has developed cutting-edge diagnostic tools that are revolutionizing the way people approach healthcare. Lonza, meanwhile, is a leading provider of biopharmaceuticals and other healthcare products, and Angelica has been instrumental in expanding the company's reach and impact.

Throughout her career, Angelica has remained committed to using her expertise to make a positive impact in the world. She has received numerous awards and accolades for her work, including being named one of Forbes 30 Under 30 in healthcare. Her dedication to using technology to improve healthcare outcomes has made her a respected leader in the industry, and she continues to be an influential voice for change and innovation in healthcare.

Angelica Kohlmann's vision is to use technology to empower individuals to take control of their own health. She believes that by leveraging the latest advancements in healthcare technology, individuals can play a more active role in their own healthcare, leading to better health outcomes and overall wellness.

Angelica is passionate about the potential of digital health to revolutionize the way people approach their health. She believes that digital health tools and solutions can help individuals track their health, identify potential health issues early on, and make informed decisions about their healthcare.